Contact this trialFirst, we need to learn more about you.
PARP Inhibitor and ATR Inhibitor
ATR Inhibitor + PARP Inhibitor for Ovarian Cancer
Recruiting1 awardPhase 2
Philadelphia, Pennsylvania
This trial will test a new combination of drugs to treat ovarian cancer. The drugs will be given to women who have had the disease come back after treatment. The study will look at if the combination is safe and works well.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.